IMR Press / CEOG / Volume 43 / Issue 3 / DOI: 10.12891/ceog2141.2016

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Case Report
Intravascular leiomyomatosis: an exceptional entity
Show Less
1 Gynecologic Oncology Unit. La Paz University Hospital. Madrid (Spain)
Clin. Exp. Obstet. Gynecol. 2016, 43(3), 443–445; https://doi.org/10.12891/ceog2141.2016
Published: 10 June 2016
Abstract

Intravenous leiomyomatosis (IVL) is a rare benign condition characterized by the proliferation of smooth muscle cells originating from either the uterine venous wall or a uterine myoma. This leiomyomatosis extends most frequently to pelvic vessels, but also occasionally into the inferior vena cava and right cardiac chambers. Preoperative diagnosis is difficult and it should be suspected in the presence of cardiac or pelvic masses in women who have undergone hysterectomy or myomectomy previously. The treatment is hysterectomy, normally associated with a bilateral oophorectomy and removing the mass or metastasis if any. The post-surgical follow-up should be performed at long term and include exploration and imaging, either ultrasound or MRI. The association of antiestrogenic drugs can be useful for disease control, especially in cases where oophorectomy is not performed and the tumor cannot be removed completely.
Keywords
Intravascular leiomyomatosis
Intravenous leiomyomatosis
Cardiac tumor
Pelvic mass
Share
Back to top